Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000228805 | SCV000288508 | benign | Acute myeloid leukemia | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000499387 | SCV000593990 | benign | not specified | 2018-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001529423 | SCV001772479 | likely benign | not provided | 2020-12-22 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25468431) |
Institute for Clinical Genetics, |
RCV001529423 | SCV002009844 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256166 | SCV002531748 | benign | Hereditary cancer-predisposing syndrome | 2020-11-20 | criteria provided, single submitter | curation | |
Prevention |
RCV003937905 | SCV004747823 | likely benign | CEBPA-related disorder | 2020-12-15 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV001529423 | SCV001742862 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529423 | SCV001808161 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529423 | SCV001972976 | likely benign | not provided | no assertion criteria provided | clinical testing |